Elizabeth Glaser Pediatric AIDS Foundation Presents Research on HIV and Children at IAS 2011

July 15, 2011
FOR IMMEDIATE RELEASE

Contact: Robert Yule, Rome, +1.202.390.9540
Stephanie Bowen, Washington, D.C., +1.202.448.8466

July 15, 2011, Rome, Italy – The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will be highlighting the latest research on issues relating to children and HIV at the 2011 International AIDS Society (IAS) conference in Rome.

The sixth International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, held July 17 – 20, is this year’s most prominent research conference on global HIV/AIDS. The Foundation will have nearly thirty representatives in attendance from the various countries in which it works, including the U.S., Cameroon, Côte d’Ivoire, Lesotho, Malawi, Mozambique, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe.

The Foundation will be presenting on the issues of pediatric AIDS and the health of HIV-positive mothers, sharing its own clinical and implementation research findings, and participating in a variety of sessions, including:

For more details about the Foundation’s activities and research presentations at IAS 2011, visit the Foundation’s IAS page (www.pedaids.org/ias2011), read updates on the blog (www.pedaids.org/What-We-re-Doing/Foundation-Blog), and follow the latest developments on Twitter (@EGPAF). Journalists can also download the Foundation’s new A Journalist’s Guide to Reporting on Pediatric HIV and AIDS (http://www.pedaids.org/Press-Room/Press-Kit/2011/EGPAFJournoToolkit), and can contact the media team above to interview Foundation staff attending IAS.

Working in 17 countries at more than 5,500 sites, the Elizabeth Glaser Pediatric AIDS Foundation is the leading global nonprofit organization dedicated to preventing pediatric HIV infection and eliminating pediatric AIDS through research, advocacy, and prevention and treatment programs. It has reached nearly 12.2 million women with PMTCT services, provided HIV care and support to more than 1.3 million children and adults, and started more than 700,000 individuals on antiretroviral treatment.

The Foundation also supports and conducts operational and clinical research to ensure children’s access to the most effective medical treatments for HIV, to assess the long-term effects of AIDS medicines on children, to increase the effectiveness of key HIV /AIDS programs in the field, and to develop a safe pediatric HIV vaccine.

To learn more about the Foundation’s research efforts toward the elimination of pediatric HIV and AIDS, visit http://www.pedaids.org/What-We-re-Doing/Research.

###